bioAffinity Technologies, Inc. (BIAF) Operating cash flow 2021–2025
bioAffinity Technologies, Inc. (BIAF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.3MFY2025 · since FY2021: -$2.0M → -$9.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.3M | -28.4% |
| FY2024 | -$7.3M | -20.3% |
| FY2023 | -$6.0M | -48.3% |
| FY2022 | -$4.1M | -98.7% |
| FY2021 | -$2.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Net marginBIAF Gross profitBIAF Gross marginBIAF Operating incomeBIAF Operating marginBIAF Free cash flowBIAF Capital expendituresBIAF Return on equityBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Total liabilitiesBIAF Shareholders’ equityBIAF overview →